Familial blood vessel tumors and subsequent cancers

Annals of Oncology

Volumn 18, Issue 7, 2007, Pages 1260-1267

  Ji, J ^a   Hemminki, K ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Familial risk; Hemangioblastoma; Hemangioma; Kaposi's sarcoma; Words: Blood vessel tumors

Indexed keywords

ANGIOSARCOMA; ARTICLE; BREAST CANCER; CALCULATION; CANCER GENETICS; CANCER RISK; DATA ANALYSIS; DATA BASE; ENDOCRINE TUMOR; FAMILIAL CANCER; HEMANGIOBLASTOMA; HEMANGIOMA; HEMANGIOPERICYTOMA; HODGKIN DISEASE; HUMAN; HYPOPHYSIS ADENOMA; IMMUNE DEFICIENCY; INCIDENCE; KAPOSI SARCOMA; KIDNEY CANCER; KIDNEY TUMOR; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MYELOMA; NERVOUS SYSTEM TUMOR; NONHODGKIN LYMPHOMA; PARENT; PATIENT COUNSELING; PRIORITY JOURNAL; PROGENY; SECOND CANCER; TUMOR LOCALIZATION; VASCULAR TUMOR; VON HIPPEL LINDAU DISEASE;

AGE FACTORS; AGE OF ONSET; BREAST NEOPLASMS; ENDOCRINE GLAND NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, VASCULAR TISSUE; PARENTS; PEDIGREE; VON HIPPEL-LINDAU DISEASE;

EID: 34547869259     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm092     Document Type: Article

References (29)

1. Weiss S, Goldblum J. Benign tumors and tumor-like lesions of blood vessels. In Weiss S, Goldblum J (eds): Enzinger and Weiss's Soft Tissue Tumors, 4th edition. St Louis, MO: Mosby Inc. 2001; 837-889.
2. Bauland CG, van Steensel MA, Steijlen PM et al. The pathogenesis of hemangiomas: A review. Plast Reconstr Surg 2006; 117: 29e-35e.
3. Weiss S, Goldblum J. Hemangioendothelioma: Vascular tumors of intermediate malignancy. In Weiss S, Goldblum J (eds): Enzinger and Weiss's Soft Tissue Tumors, 4th edition. St Louis, MO: Mosby Inc. 2001.
4. Weiss S, Goldblum J. Malignant vascular tumors. In Weiss S, Goldblum J (eds): Enzinger and Weiss's Soft Tissue Tumors, 4th edition. St Louis, MO: Mosby Inc. 2001.
5. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft fissue: A study of 80 cases. Am J Surg Pathol 1998; 22: 683-697.
6. Sordillo EM, Sordillo PP, Hajdu SI, Good RA. Lymphangiosarcoma after filarial infection. J Dermatol Surg Oncol 1981; 7: 235-239.
7. Cafiero F, Gipponi M, Peressini A et al. Radiation-associated angiosarcoma: Diagnostic and therapeutic implications - two case reports and a review of the literature. Cancer 1996; 77: 2496-2502.
8. Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
9. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998; 90: 1039-1071.
10. Zbar B, Kishida T, Chen F et al. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996; 8: 348-357.
11. Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes, Oncogene 2004; 23: 6445-6470.
12. Hemminki K, Li X, Pine K et al. The nation-wide Swedish family-cancer database - updated structure and familial rates. Acta Oncol 2001; 40: 772-777.
13. Hemminki K, Granstrom C, Chen B. The Swedish Family-Cancer Database: update, application to colorectal cancer and clinical relevance. Hered Cancer Clin Pract 2005; 3: 7-18.
14. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001; 92: 144-150.
15. Center for Epidemiology. Cancer Incidence in Sweden 2000. Stockholm, Sweden: The National Board of Health and Welfware 2002.
16. Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research. Lyon, France: IARC 1994.
17. Center for Epidemiology. Cancer incidence in Sweden 2002. In edition. Stockholm: The National Board of Health and Welfare 2004; http://www.sos.se/FULLTEXT/42/2003-42-11/2003-42-11.pdf.
18. Brannstrom J, Akerlund B, Ameborn M et al. Patents unaware of their HIV infection until AIDS diagnosis in Sweden 1996-2002 - a remaining problem in the highly active antiretroviral therapy era. Int J STD AIDS 2005; 16: 702-706.
19. Tihan T, Chi JH, McCormick PC et al. Pathologic and epidemiologic findings of intramedullary spinal cord tumors. Neurosurg Clin N Am 2006; 17: 7-11.
20. Shuin T, Yamasaki I, Tamura K et al. Von hippel-lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol 2006; 36: 337-343.
21. Hemminki K, Li X, Collins VP. A population-based study of familial central nervous system hemangioblastomas. Neuroepidemiology 2001; 20: 257-261.
22. Glasker S. Central nervous system manifestations in VHL: Genetics, pathology and clinical phenotypic features. Fam Cancer 2005; 4: 37-42.
23. Moore PS, Missiaglia E, Antonello D et al. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. Genes Chromosomes Cancer 2001; 32: 177-181.
24. Elias WJ, Hussaina IM, Chadduck JB et al. Hemangiopericytoma in the setting of acromegaly. Endocr Pathol 2002; 13: 251-261.
25. DeLellis R, Loyd R, Heitz P, Eng C. Pathology and Genetics of Tumours of Endocrine Origin. Lyon, France: IARC press 2004.
26. Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Arch Dermatol Res 2001; 293: 296-301.
27. Brown LF, Tognazzi K, Dvorak HF, Harrist TJ. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/ vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 1996; 148: 1065-1074.
28. Mercurio AM, Lipscomb EA, Bachelder RE. Non-angiogenic functions of VEGF in breast cancer. J Mammary Gland Biol Neoplasia 2005; 10: 283-290.
29. Safai B. Kaposi's sarcoma: A review of the classical and epidemic forms. Ann N Y Acad Sci 1984; 437: 373-382.